Effects of combined pioglitazone and metformin on diabetes and obesity in Wistar fatty rats (Q43977158)

28 November 2017

Effects of combined pioglitazone and metformin on diabetes and obesity in Wistar fatty rats (English)

1 reference

28 November 2017

1 reference

Masami Suzuki

1

1 reference

28 November 2017

Hiroyuki Odaka

2

1 reference

28 November 2017

Noriko Suzuki

3

1 reference

28 November 2017

Yasuo Sugiyama

4

1 reference

28 November 2017

Hitoshi Ikeda

5

1 reference

28 November 2017

1 April 2002

1 reference

Clinical and Experimental Pharmacology and Physiology

28 November 2017

1 reference

28 November 2017

29

1 reference

28 November 2017

4

1 reference

28 November 2017

269-274

1 reference

Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study.

28 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.03644.X

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.03644.X

Metformin's effects on glucose and lipid metabolism in patients with secondary failure to sulfonylureas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.03644.X

A comparison of acarbose versus metformin as an adjuvant therapy in sulfonylurea-treated NIDDM patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.03644.X

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.03644.X

Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.03644.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.03644.X

Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: a randomized, placebo-controlled study. The Pioglitazone 027 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.03644.X

Pioglitazone Increases Insulin Sensitivity by Activating Insulin Receptor Kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.03644.X

Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.03644.X

Sulfated glycans stimulate endocytosis of the cellular isoform of the prion protein, PrPC, in cultured cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.03644.X

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.03644.X

Regulation of PPAR gamma gene expression by nutrition and obesity in rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.03644.X

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.03644.X

Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.03644.X

Pioglitazone time-dependently reduces tumour necrosis factor-alpha level in muscle and improves metabolic abnormalities in Wistar fatty rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.03644.X

Role of metformin in treatment of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.03644.X

Improvement with metformin in insulin internalization and processing in monocytes from NIDDM patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.03644.X

Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.03644.X

Cellular mechanism of action of metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.03644.X

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.03644.X

Effects of metformin on the pathways of glucose utilization after oral glucose in non-insulin-dependent diabetes mellitus patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.03644.X

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.03644.X

Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.03644.X

Effect of metformin on food intake in obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.03644.X

Increased adipose expression of the uncoupling protein-3 gene by thiazolidinediones in Wistar fatty rats and in cultured adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.03644.X

Effect of chronic metformin treatment of hepatic and muscle glycogen metabolism in KK mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.03644.X

Specific Inhibition of Gluconeogenesis by Biguanides

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.03644.X

10.1046/J.1440-1681.2002.03644.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference